Tissue Diagnostics: Technologies and Global Markets

Tissue Diagnostics: Technologies and Global Markets

Report Scope

The report provides an analysis of the tissue diagnostics market, along with a competitive landscape and profiles of leading companies that include their revenues, product portfolios and recent activities. The report analyzes market dynamics, including drivers, limitations, challenges and opportunities, and discusses current and potential market size. The report will enable companies in the industry to make informed decisions about the production and licensing of goods and services. Organizations, distributors and exporters should find useful information about market developments and trends.

The study segments the market on multiple bases. By product type, the market is segmented into instruments and reagents (reagents/test kits/consumables of tissue diagnostics).

By segment type, the market is divided into histopathology, which includes hematoxylin and eosin stains (H&E) and immunohistochemistry (IHC); molecular pathology, which includes in situ hybridization (ISH), polymerase chain reaction (PCR) and next-generation sequencing (NGS); microbiological testing, which includes general culture testing and antimicrobial susceptibility testing and identification (AST/ID); and digital pathology.

Regional market analysis is provided for all the major segments. The regions are North America; Europe; Asia-Pacific; Latin America; and Rest of the World (RoW), which in this report consists of the Middle East and Africa. The report also provides country-level analyses of markets and market segments.

The report covers only tissue sample-based tests. The liquid biopsy market; swab, saliva and urine-based tests; and the service testing market of tissue diagnostics are outside the scope of the report.

In this report, the tissue diagnostics market is segmented by:

Product type:

Reagents.

Instruments.

Segments:

Histopathology (H&E, IHC).

Molecular pathology (ISH, PCR and NGS).

Microbiological testing (general culture testing, AST/ID testing) .

Digital pathology.

Technology:

H&E.

IHC.

ISH.

PCR.

NGS.

Digital pathology.

Applications:

Oncology.

Tissue typing.

Pathogen detection and AST.

End users:

Professional laboratories.

Emergency care units.

Academic and research institutes.

Report Includes

40 data tables and 42 additional tables

An analysis of the global market trends for tissue diagnostics, with market revenue data from 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029

Estimates of the size and revenue prospects of the global market, along with a market share analysis by type of test, technology, application, end user and region

Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of macroeconomic factors

Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses

An analysis of patents, emerging trends and developments in the industry

Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

Company profiles of major players within the industry, including F. Hoffmann-La Roche Ltd., Danaher Corp., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and Illumina Inc.

Companies Mentioned

Abbott
Agilent Technologies Inc.
Bd
Biocare Medical Llc.
Biomerieux
Bio-rad Laboratories Inc.
Danaher Corp.
F. Hoffmann-la Roche Ltd.
Illumina Inc.
Koninklijke Philips N.V.
Merck Kgaa
Myriad Genetics Inc.
Qiagen
Thermo Fisher Scientific Inc.
Zytovision Gmbh